🇺🇸 Glimepirde in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain Upper — 1 report (10%)
  2. Anaemia — 1 report (10%)
  3. Blood Glucose Abnormal — 1 report (10%)
  4. Blood Glucose Decreased — 1 report (10%)
  5. Blood Glucose Increased — 1 report (10%)
  6. Bronchitis — 1 report (10%)
  7. Cerebrovascular Accident — 1 report (10%)
  8. Circumstance Or Information Capable Of Leading To Medication Error — 1 report (10%)
  9. Device Malfunction — 1 report (10%)
  10. Diarrhoea — 1 report (10%)

Source database →

Glimepirde in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Glimepirde approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glimepirde in United States?

Seoul National University Bundang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.